The coronary haemodynamic effect of atenolol, a new cardioselective beta-adrenergic blocker, was studied in 15 patients with angina pectoris.Myocardial blood flow from the anterolateral part of the left ventricle was measured by the continuous infusion thermodilution method by means of a two-thermistor catheter with pacing electrodes placed in the great cardiac vein. Catheters were also positioned in the pulmonary artery and the thoracic aorta for blood sampling, pressure measurements, and cardiac output determination. Investigations were performed at rest, at slow, and at submaximal atrial pacing rates before and 10 minutes after injection of 5 mg atenolol intravenously. Coronary angiography was performed in all patients.Atenolol reduced resting myocardial blood flow by 16 per cent (P<0-001) and oxygen consumption by 17 per cent (P<0-001). Flow was reduced whether or not the part of myocardium in question was supplied by a stenotic artery. Coronary arteriolar resistance increased by 23 per cent (P<0 001). Myocardial arteriovenous oxygen difference was not affected. Heart rate and rate-pressure index were reduced in all patients (P<0-001). When the heart rate was kept constant by atrial pacing there was no change in the rate-pressure index and no change in any of the coronary haemodynamic values. A small but highly significant increase of 2 mmHg± 0*4 (SEM) in left ventricularfilling pressure was observed at rest (P<0-001), and 4 mmHg± 07 (P=0-001) during submaximal pacing. In all three situations theflow per unit left ventricular pressure work was identical before and after atenolol.It is concluded that the decrement in myocardial bloodflow and oxygen consumption effected by the drug could be attributed solely to the reduction in left ventricular work. No direct effect on coronary resistance could be identified. By reducing left ventricular work atenolol will be effective in the treatment of ischaemic heart disease. Since it increases left ventricular filling pressure it must be used with care in patients with latent heart failure.